MacroGenics, Inc. (MGNX)

MacroGenics Revenue

In the year 2023, MacroGenics had annual revenue of $58.75M, a decrease of -61.33%. Revenue in the quarter ending December 31, 2023 was $10.72M, a -85.33% decrease year-over-year.

• Revenue (ttm): $58.75M
• Revenue Growth: -61.33%
• P/S Ratio: 16.07
• Revenue / Employee: $173,301
• Employees: 339
• Market Cap: 944.09M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	58.75M	-93.19M	-61.33%
Dec 31, 2022	151.94M	74.49M	96.19%
Dec 31, 2021	77.45M	-27.44M	-26.16%
Dec 31, 2020	104.88M	40.70M	63.40%
Dec 31, 2019	64.19M	4.07M	6.76%
Dec 31, 2018	60.12M	-97.62M	-61.89%
Dec 31, 2017	157.74M	65.86M	71.68%
Dec 31, 2016	91.88M	-8.97M	-8.90%
Dec 31, 2015	100.85M	53.06M	111.00%
Dec 31, 2014	47.80M	-10.24M	-17.64%
Dec 31, 2013	58.04M	-5.79M	-9.07%
Dec 31, 2012	63.83M	6.62M	11.57%
Dec 31, 2011	57.21M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.